To understand the molecular mechanism by which S. aureus activates the MEK1/2 pathway, we analyzed transcriptome data from femurs of mice with S. aureus-induced osteomyelitis and control samples on day 14 post-infection (GEO: GSE166522) from our previous work [27]. This evidence concerns the gene MAP2K1 and osteomyelitis.